Moleculin Biotech Stock Price

-0.0215 (-0.73%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0215 -0.73% 2.9385 10:01:19
Open Price Low Price High Price Close Price Prev Close
2.95 2.9275 2.9699 2.96
Bid Price Ask Price Spread News
2.93 2.97 0.04 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
46 5,247 $ 2.95 $ 15,487 - 0.6526 - 8.78
Last Trade Time Type Quantity Stock Price Currency
10:00:42 4 $ 2.945 USD


Draw Mode:

Moleculin Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 83.90M 28.55M 27.98M $ - $ - -1.73 -3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 578.28k 2.40%

more financials information »

Moleculin Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MBRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.033.042.802.90156,414-0.0915-3.02%
1 Month3.003.202.803.01122,004-0.0615-2.05%
3 Months3.573.742.703.15176,786-0.6315-17.69%
6 Months3.844.772.703.83643,171-0.9015-23.48%
1 Year0.808.780.65263.041,583,8162.14267.31%
3 Years1.618.780.3231.781,673,1441.3382.52%
5 Years5.578.780.3231.861,326,477-2.63-47.24%

Moleculin Biotech Description

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Your Recent History
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.